AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site
US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 employees following expansion Construction will commence immediately with facilities becoming operational in...